New study to reveal hidden heart risks of hormone therapy in transgender people
NCT ID NCT07394400
First seen Feb 06, 2026 · Last updated May 23, 2026 · Updated 14 times
Summary
This observational study will follow 94 transgender individuals (ages 16+) starting gender-affirming hormone therapy to see how it impacts their heart health, metabolism, and mood. Researchers will measure inflammation, blood vessel function, and emotional well-being at the start, 6 months, and 12 months. The goal is to improve healthcare tailored to transgender people.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for TRANSGENDER INDIVIDUALS are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Hospital Universitario Doctor Peset
Valencia, Valencia, 46017, Spain
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.